Item 1. Financial Statements
Item 1. Financial Statements.
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands, except par value data)
June 30,
2022
September 30,
2021
(Unaudited)
Assets
Current assets:
Cash and cash equivalents
$
101,318
$
400,959
Trade accounts receivable, net
31,462
32,623
Accounts receivable, other
35,911
33,958
Inventory
1,014,622
871,349
Other current assets
59,806
44,686
Total current assets
1,243,119
1,383,575
Property and equipment, net of accumulated depreciation of $ 808,298 at
June 30, 2022, and $ 767,403 at September 30, 2021
289,814
307,377
Operating lease assets
549,493
537,673
Goodwill
533,147
541,209
Intangible assets, excluding goodwill, net of accumulated amortization of
$ 40,336 at June 30, 2022, and $ 38,957 at September 30, 2021
50,386
55,532
Other assets
19,907
21,766
Total assets
$
2,685,866
$
2,847,132
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt
$
167,169
$
194
Accounts payable
279,359
291,632
Accrued liabilities
165,996
206,155
Current operating lease liabilities
159,452
156,234
Income taxes payable
2,985
10,666
Total current liabilities
774,961
664,881
Long-term debt
1,083,924
1,382,530
Long-term operating lease liabilities
421,072
404,147
Other liabilities
16,781
29,056
Deferred income tax liabilities, net
93,257
85,777
Total liabilities
2,389,995
2,566,391
Stockholders’ equity:
Common stock, $ 0.01 par value. Authorized 500,000 shares; 107,017 and
113,138 shares issued and 106,963 and 112,913 shares outstanding at
June 30, 2022, and September 30, 2021, respectively
1,070
1,129
Preferred stock, $ 0.01 par value. Authorized 50,000 shares; none issued
—
—
Additional paid-in capital
2,339
17,286
Accumulated earnings
418,832
356,967
Accumulated other comprehensive loss, net of tax
( 126,370
)
( 94,641
)
Total stockholders’ equity
295,871
280,741
Total liabilities and stockholders’ equity
$
2,685,866
$
2,847,132
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Earnings
(In thousands, except per share data)
(Unaudited)
Three Months Ended
Nine Months Ended
June 30,
June 30,
2022
2021
2022
2021
Net sales
$
961,467
$
1,022,387
$
2,853,105
$
2,884,737
Cost of goods sold
471,259
507,981
1,397,436
1,432,378
Gross profit
490,208
514,406
1,455,669
1,452,359
Selling, general and administrative expenses
390,961
386,481
1,156,082
1,143,738
Restructuring
44
508
1,143
1,371
Operating earnings
99,203
127,417
298,444
307,250
Interest expense
35,977
23,452
76,113
73,313
Earnings before provision for income taxes
63,226
103,965
222,331
233,937
Provision for income taxes
16,659
27,759
60,117
62,228
Net earnings
$
46,567
$
76,206
$
162,214
$
171,709
Earnings per share:
Basic
$
0.44
$
0.68
$
1.48
$
1.52
Diluted
$
0.43
$
0.66
$
1.46
$
1.50
Weighted-average shares:
Basic
106,940
112,739
109,238
112,605
Diluted
108,526
114,927
110,907
114,274
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income
(In thousands)
(Unaudited)
Three Months Ended
Nine Months Ended
June 30,
June 30,
2022
2021
2022
2021
Net earnings
$
46,567
$
76,206
$
162,214
$
171,709
Other comprehensive (loss) income:
Foreign currency translation adjustments
( 27,384
)
6,617
( 34,645
)
23,734
Interest rate caps, net of tax
2,050
471
2,328
646
Foreign exchange contracts, net of tax
432
( 191
)
588
( 1,211
)
Other comprehensive (loss) income, net of tax
( 24,902
)
6,897
( 31,729
)
23,169
Total comprehensive income
$
21,665
$
83,103
$
130,485
$
194,878
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity
(In thousands)
(Unaudited)
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Accumulated
Comprehensive
Stockholders’
Shares
Amount
Capital
Earnings
Loss
Equity
Balance at September 30, 2021
112,913
$
1,129
$
17,286
$
356,967
$
( 94,641
)
$
280,741
Net earnings
—
—
—
68,838
—
68,838
Other comprehensive loss
—
—
—
—
( 3,751
)
( 3,751
)
Share-based compensation
—
—
3,958
—
—
3,958
Stock issued for equity awards
795
8
7,364
—
—
7,372
Employee withholding taxes paid
related to net share settlement
( 56
)
( 1
)
( 1,136
)
—
—
( 1,137
)
Repurchases and cancellations of
common stock
( 3,675
)
( 36
)
( 27,472
)
( 47,492
)
—
( 75,000
)
Balance at December 31, 2021
109,977
$
1,100
$
—
$
378,313
$
( 98,392
)
$
281,021
Net earnings
—
—
—
46,808
—
46,808
Other comprehensive loss
—
—
—
—
( 3,076
)
( 3,076
)
Share-based compensation
—
—
2,032
—
—
2,032
Stock issued for equity awards
111
1
423
—
—
424
Employee withholding taxes paid
related to net share settlement
( 1
)
—
( 15
)
—
—
( 15
)
Repurchases and cancellations of
common stock
( 3,157
)
( 32
)
( 2,440
)
( 52,856
)
—
( 55,328
)
Balance at March 31, 2022
106,930
$
1,069
$
—
$
372,265
$
( 101,468
)
$
271,866
Net earnings
—
—
—
46,567
—
46,567
Other comprehensive loss
—
—
—
—
( 24,902
)
( 24,902
)
Share-based compensation
—
—
2,113
—
—
2,113
Stock issued for equity awards
35
1
253
—
—
254
Employee withholding taxes paid
related to net share settlement
( 2
)
—
( 27
)
—
—
( 27
)
Balance at June 30, 2022
106,963
$
1,070
$
2,339
$
418,832
$
( 126,370
)
$
295,871
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Accumulated
Comprehensive
Stockholders’
Shares
Amount
Capital
Earnings
Loss
Equity
Balance at September 30, 2020
112,405
$
1,124
$
1,913
$
117,109
$
( 104,703
)
$
15,443
Net earnings
—
—
—
57,191
—
57,191
Other comprehensive income
—
—
—
—
23,588
23,588
Share-based compensation
—
—
2,893
—
—
2,893
Stock issued for equity awards
158
2
( 2
)
—
—
—
Employee withholding taxes paid
related to net share settlement
( 25
)
( 1
)
( 248
)
—
—
( 249
)
Balance at December 31, 2020
112,538
$
1,125
$
4,556
$
174,300
$
( 81,115
)
$
98,866
Net earnings
—
—
—
38,312
—
38,312
Other comprehensive loss
—
—
—
—
( 7,316
)
( 7,316
)
Share-based compensation
—
—
2,648
—
—
2,648
Stock issued for equity awards
141
2
2,321
—
—
2,323
Balance at March 31, 2021
112,679
$
1,127
$
9,525
$
212,612
$
( 88,431
)
$
134,833
Net loss
—
—
—
76,206
—
76,206
Other comprehensive income
—
—
—
—
6,897
6,897
Share-based compensation
—
—
2,617
—
—
2,617
Stock issued for stock options
101
1
1,716
—
—
1,717
Balance at June 30, 2021
112,780
$
1,128
$
13,858
$
288,818
$
( 81,534
)
$
222,270
The accompanying notes are an integral part of these condensed consolidated financial statements.
7
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Nine Months Ended June 30,
2022
2021
Cash Flows from Operating Activities:
Net earnings
$
162,214
$
171,709
Adjustments to reconcile net earnings to net cash provided by operating
activities:
Depreciation and amortization
73,361
78,090
Share-based compensation expense
8,103
8,158
Amortization of deferred financing costs
2,702
3,280
Loss on early extinguishment of debt
16,439
2,449
Loss on disposal of equipment and other property
57
1,638
Deferred income taxes
7,702
( 998
)
Changes in (exclusive of effects of acquisitions):
Trade accounts receivable
243
( 8,612
)
Accounts receivable, other
( 3,034
)
( 10,363
)
Inventory
( 160,194
)
( 108,317
)
Other current assets
( 15,577
)
( 931
)
Other assets
3,547
1,578
Operating leases, net
8,448
( 1,595
)
Accounts payable and accrued liabilities
( 34,349
)
78,250
Income taxes payable
( 8,169
)
6,372
Other liabilities
( 12,266
)
( 2,980
)
Net cash provided by operating activities
49,227
217,728
Cash Flows from Investing Activities:
Payments for property and equipment, net of proceeds
( 67,234
)
( 44,888
)
Acquisitions, net of cash acquired
( 665
)
( 2,351
)
Net cash used by investing activities
( 67,899
)
( 47,239
)
Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt
283,003
—
Repayments of long-term debt, including prepayment costs
( 433,383
)
( 418,986
)
Debt issuance costs
—
( 1,300
)
Payments for common stock repurchased
( 130,328
)
—
Proceeds from equity awards
8,050
4,039
Employee withholding taxes paid related to net share settlement of equity awards
( 1,179
)
( 249
)
Net cash used by financing activities
( 273,837
)
( 416,496
)
Effect of foreign exchange rate changes on cash and cash equivalents
( 7,132
)
2,173
Net decrease in cash and cash equivalents
( 299,641
)
( 243,834
)
Cash and cash equivalents, beginning of period
400,959
514,151
Cash and cash equivalents, end of period
$
101,318
$
270,317
Supplemental Cash Flow Information:
Interest paid
$
75,660
$
86,293
Income taxes paid
$
73,862
$
53,764
Capital expenditures incurred but not paid
$
7,682
$
2,098
The accompanying notes are an integral part of these condensed consolidated financial statements.
8
Sally Beauty Holdings, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. Significant Accounting Policies
Business Operations
Sally Beauty Holdings is an international specialty retailer and distributor of professional beauty supplies with operations in North America, South America and Europe. We are one of the largest distributors of professional beauty supplies in the U.S. based on store count, operating under two segments, Sally Beauty Supply (“SBS”) and Beauty Systems Group (“BSG”). Our operations consist of company-operated stores, franchise stores and several e-commerce platforms. Within BSG, we also have one of the largest networks of distributor sales consultants (“DSCs”) for professional beauty products in North America, who sell directly to salons and salon professionals. SBS targets retail consumers, salons and salon professionals, while BSG targets salons and salon professionals.
Basis of Presentation
The condensed consolidated interim financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. In the opinion of management, these condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly our consolidated financial position as of June 30, 2022, and September 30, 2021, and our consolidated results of operations, consolidated comprehensive income, consolidated statements of stockholders’ equity for the three and nine months ended June 30, 2022 and 2021, and our consolidated cash flows for the nine months ended June 30, 2022 and 2021.
Principles of Consolidation
The condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. All amounts are in U.S. Dollars.
Accounting Policies
We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.
Use of Estimates
In order to present our financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable information available, however are subject to change in the future. Additionally, unknown future impacts of COVID-19 may impact those estimates and assumptions as well. Significant estimates and assumptions are part of our accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangibles and goodwill, and other reserves. We believe these estimates and assumptions are reasonable; however, they are based on management’s current knowledge of events and actions, and changes in facts and circumstances may result in revised estimates and impact actual results.
Impact of COVID-19
Our operating results for the fiscal years 2022 and 2021 were adversely impacted by the COVID-19 pandemic and its effects on the global economy. Given the uncertainty around the continued effects of the COVID-19 pandemic and macro-environment, we cannot reasonably predict the effect they will have on future periods. If once again we become materially and adversely impacted, we may have to consider adjustments to our operations, inventory, liquidity, capital expenditures and accounting estimates and reserves.
9
2. Revenue Recognition
Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale. Revenue is recognized net of estimated sales returns and sales taxes. We estimate sales returns based on historical data.
Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, for the periods were as follows (in thousands):
Nine Months Ended June 30,
2022
2021
Beginning Balance
$
16,744
$
13,947
Loyalty points and gift cards issued but not redeemed, net of estimated breakage
5,195
11,950
Revenue recognized from beginning liability
( 8,132
)
( 9,391
)
Ending Balance
$
13,807
$
16,506
See Note 10, Segment Reporting , for additional information regarding the disaggregation of our sales revenue.
3. Fair Value Measurements
Financial instruments measured on recurring basis
Consistent with the three-level hierarchy defined in ASC Topic 820, Fair Value Measurement , as amended, we categorize our financial assets and liabilities as follows:
(in thousands)
Classification
Fair Value Hierarchy Level
June 30,
2022
September 30,
2021
Financial Assets:
Foreign exchange contracts
Other current assets
Level 2
$
547
$
—
Interest rate caps
Other assets
Level 2
2,029
35
Total assets
$
2,576
$
35
.
Financial Liabilities:
Foreign exchange contracts
Accrued liabilities
Level 2
$
315
$
—
Financial instruments not measured at fair value
Carrying amounts and the related estimated fair value of our long-term debt, excluding capital lease obligations and debt issuance costs, are as follows:
June 30, 2022
September 30, 2021
(in thousands)
Fair Value Hierarchy Level
Carrying Value
Fair Value
Carrying Value
Fair Value
Long-term debt, excluding capital leases
Senior notes
Level 1
$
679,961
$
638,313
$
979,961
$
1,019,635
Term loan B
Level 2
408,875
403,764
413,000
411,451
Total long-term debt
$
1,088,836
$
1,042,077
$
1,392,961
$
1,431,086
The table above excludes amounts, if any, related to our ABL facility as the balance approximates fair value due to the short-term nature of our borrowings. The fair value of the senior notes was measured using unadjusted quoted market prices. The fair value of Term Loan B was measured using quoted market prices for similar debt securities in active markets or widely accepted valuation techniques, such as discounted cash flow analyses, using observable inputs, such as market interest rates.
10
4. Stockholders’ Equity
Share Repurchases
In August 2017, our Board of Directors approved a share repurchase program authorizing the Company to repurchase up to $ 1.0 billion of its common stock, subject to certain limitations governed by our debt agreements. In July 2021, our Board of Directors approved a term extension of the share repurchase program for the four-year period ending September 30, 2025 . As of June 30, 2022, we had authorization of approximately $ 595.8 million of additional potential share repurchases remaining under our share repurchase program.
Information related to our shares repurchased and subsequently retired were as follows (in thousands):
Three Months Ended
June 30,
Nine Months Ended
June 30,
2022
2021
2022
2021
Number of shares repurchased
—
—
6,832
—
Total cost of share repurchased
$
—
$
—
$
130,328
$
—
Accumulated Other Comprehensive Loss
The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):
Foreign Currency Translation Adjustments
Interest Rate Caps
Foreign Exchange Contracts
Total
Balance at September 30, 2021
$
( 92,154
)
$
( 2,085
)
$
( 402
)
$
( 94,641
)
Other comprehensive loss before
reclassification, net of tax
( 34,645
)
1,073
400
( 33,172
)
Reclassification to net earnings, net of tax
—
1,255
188
1,443
Balance at June 30, 2022
$
( 126,799
)
$
243
$
186
$
( 126,370
)
The tax impact for the changes in other comprehensive loss and the reclassifications to net earnings was not material.
5. Weighted-Average Shares
The following table sets forth the reconciliation of basic and diluted weighted-average shares (in thousands):
Three Months Ended
June 30,
Nine Months Ended
June 30,
2022
2021
2022
2021
Weighted-average basic shares
106,940
112,739
109,238
112,605
Dilutive securities:
Stock option and stock award programs
1,586
2,188
1,669
1,669
Weighted-average diluted shares
108,526
114,927
110,907
114,274
Anti-dilutive options excluded from our computation of diluted shares
2,406
2,188
2,385
1,670
6. Goodwill and Intangible Assets
During our second fiscal quarter, we completed our annual assessment for impairment of goodwill and indefinite-lived intangible assets. For goodwill, we used a qualitative analysis and our actual and forecasted results are exceeding the estimates from the last quantitative test. Additionally, we considered potential triggering events and determined there were none for the three months ended June 30, 2022. No material impairment losses were recognized in the current or prior periods presented in connection with our goodwill and other intangible assets.
Three Months Ended
June 30,
Nine Months Ended
June 30,
(in thousands)
2022
2021
2022
2021
Intangible assets amortization expense
$
977
$
1,648
$
3,047
$
4,956
Additionally, during the nine months ended June 30, 2022, the decreases in goodwill and other intangibles were primarily from the effects of foreign currency exchange rates of $ 8.3 million and $2.2 million, respectively.
11
7. Accrued Liabilities
Accrued liabilities consist of the following (in thousands):
June 30,
2022
September 30,
2021
Compensation and benefits
$
67,664
$
73,344
Deferred revenue
16,216
18,543
Rental obligations
11,187
10,501
Insurance reserves
6,098
5,934
Interest payable
3,722
24,101
Property and other taxes
2,497
3,853
Operating accruals and other
58,612
69,879
Total accrued liabilities
$
165,996
$
206,155
8. Short-term Borrowings and Long-term Debt
During the three months ended June 30, 2022, we issued a notice of redemption (the “Redemption Notice”), to redeem on May 31, 2022, the entire $ 300 million aggregate outstanding principal amount of the 8.75 % Senior Secured Second Lien Notes due 2025 (“8.75% Senior Notes”). The redemption was made pursuant to the terms of the Indenture dated April 24, 2020, at a redemption price equal to 104.375 % of the principal amount of the 8.75% Senior Notes plus accrued but unpaid interest to, but not including, the redemption date. On May 31, 2022, we redeemed these 8.75 % Senior Notes with excess cash on hand and $ 150.0 million in borrowings from our ABL facility. In connection with the redemption, we recognized a loss on the extinguishment of debt of $ 16.4 million within interest expense, which included a redemption premium of $ 13.1 million and the write-off of unamortized deferred financing costs of $ 3.3 million .
At June 30, 2022, our ABL facility had $ 167.0 million in outstanding borrowings and $ 314.2 million available for borrowing, including the Canadian sub-facility, subject to the conditions contained therein.
9. Derivative Instruments and Hedging Activities
During the nine months ended June 30, 2022, we did no t purchase or hold any derivative instruments for trading or speculative purposes. See Note 3, Fair Value Measurements , for the classification and fair value of our derivative instruments.
Designated Cash Flow Hedges
Foreign Currency Forwards
We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on inventory purchases in U.S. dollars by our foreign subsidiaries. At June 30, 2022, we held forwards, which expire ratably through September 30, 2022 , with a notional amount, based upon exchange rates at June 30, 2022, as follows (in thousands):
Notional Currency
Notional Amount
Mexican Peso
$
6,478
Euro
4,084
Canadian Dollar
2,619
Total
$
13,181
Quarterly, the changes in fair value related to the foreign currency forwards are recorded into AOCL. As the forwards are exercised, the realized value is recognized into cost of goods sold, based on inventory turns, in our condensed consolidated statements of earnings. For the nine months ended June 30, 2022 and 2021, we recognized a loss of $ 0.2 million and a gain of $ 0.1 million, respectively. The effects of our foreign currency forwards were not material for the three months ended June 30, 2022 and 2021. Based on June 30, 2022, valuations and exchange rates, we expect to reclassify gains of approximately $ 1.6 million into cost of goods sold over the next 12 months.
12
Interest Rate Caps
In July 2017, we purchased two interest rate caps with an initial aggregate notional amount of $ 550 million (the “interest rate caps”) to mitigate the exposure to higher interest rates in connection with our term loan B. The interest rate caps are comprised of individual caplets that expire ratably through June 30, 2023 , and are designated as cash flow hedges. Accordingly, changes in fair value of the interest rate caps are recorded quarterly, net of income tax, and are included in AOCL.
For the nine months ended June 30, 2022 and 2021, we recognized expense of $ 1.3 million and $ 0.8 million, respectively, into interest expense on our condensed consolidated statements of earnings. The effects of our interest rate caps on our condensed consolidated statements of earnings were not material for the three months ended June 30, 2022 and 2021. Over the next 12 months, we expect to reclassify approximately $ 0.7 million into interest expense, which represents the original value of the expiring caplets.
10. Segment Reporting
Segment data for the three and nine months ended June 30, 2022 and 2021, is as follows (in thousands):
Three Months Ended
June 30,
Nine Months Ended
June 30,
2022
2021
2022
2021
Net sales:
Sally Beauty Supply ("SBS")
$
551,725
$
602,681
$
1,639,040
$
1,693,015
Beauty Systems Group ("BSG")
409,742
419,706
1,214,065
1,191,722
Total
$
961,467
$
1,022,387
$
2,853,105
$
2,884,737
Earnings before provision for income taxes:
Segment operating earnings:
SBS
$
88,792
$
116,784
$
270,355
$
311,975
BSG
56,067
55,265
160,621
151,680
Segment operating earnings
144,859
172,049
430,976
463,655
Unallocated expenses
45,612
44,124
131,389
155,034
Restructuring
44
508
1,143
1,371
Consolidated operating earnings
99,203
127,417
298,444
307,250
Interest expense
35,977
23,452
76,113
73,313
Earnings before provision
for income taxes
$
63,226
$
103,965
$
222,331
$
233,937
Sales between segments, which are eliminated in consolidation, were not material during the three and nine months ended June 30, 2022 and 2021.
Disaggregation of net sales by segment
The following tables disaggregate our segment revenues by merchandise category. We have reclassified certain prior year amounts to conform to current year presentation.
Three Months Ended
June 30,
Nine Months Ended
June 30,
SBS
2022
2021
2022
2021
Hair color
38.3
%
36.4
%
37.7
%
36.1
%
Hair care
23.5
%
22.1
%
23.8
%
21.6
%
Styling tools and supplies
18.8
%
21.3
%
19.4
%
22.4
%
Nail
11.3
%
10.9
%
10.8
%
10.8
%
Skin and cosmetics
7.6
%
8.5
%
7.6
%
8.4
%
Other beauty items
0.5
%
0.8
%
0.7
%
0.7
%
Total
100.0
%
100.0
%
100.0
%
100.0
%
13
Three Months Ended
June 30,
Nine Months Ended
June 30,
BSG
2022
2021
2022
2021
Hair color
42.3
%
44.3
%
42.4
%
42.4
%
Hair care
40.0
%
37.2
%
39.9
%
38.4
%
Styling tools and supplies
11.4
%
11.6
%
11.2
%
11.7
%
Skin and cosmetics
3.4
%
3.7
%
3.9
%
4.1
%
Nail
2.5
%
2.7
%
2.3
%
2.9
%
Other beauty items
0.4
%
0.5
%
0.3
%
0.5
%
Total
100.0
%
100.0
%
100.0
%
100.0
%
The following tables disaggregate our segment revenue by sales channels:
Three Months Ended
June 30,
Nine Months Ended
June 30,
SBS
2022
2021
2022
2021
Company-operated stores
94.0
%
94.2
%
94.0
%
93.7
%
E-commerce
6.0
%
5.7
%
6.0
%
6.2
%
Franchise stores
0.0
%
0.1
%
0.0
%
0.1
%
Total
100.0
%
100.0
%
100.0
%
100.0
%
Three Months Ended
June 30,
Nine Months Ended
June 30,
BSG
2022
2021
2022
2021
Company-operated stores
66.6
%
69.2
%
66.9
%
69.7
%
Distributor sales consultants
13.9
%
14.1
%
13.9
%
14.0
%
E-commerce
11.6
%
8.8
%
11.8
%
8.8
%
Franchise stores
7.9
%
7.9
%
7.4
%
7.5
%
Total
100.0
%
100.0
%
100.0
%
100.0
%
14
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.